Histone deacetylase inhibition: a novel approach to cancer treatment

od Cheson, B D
Izdano 2006

The origin of the chemiluminescence of phagocytosing granulocytes.

od Cheson, B D, Christensen, R L, Sperling, R, Kohler, B E, Babior, B M
Izdano 1976

Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront...

od Czuczman, M. S., Leonard, J. P., Jung, S., Johnson, J. L., Hsi, E. D., Byrd, J. C., Cheson, B. D.
Izdano u Ann Oncol (2012)

Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront...

od Czuczman, M S, Leonard, J P, Jung, S, Johnson, J L, Hsi, E D, Byrd, J C, Cheson, B D
Izdano u Ann Oncol (2018)

Serious pulmonary toxicity in patients with Hodgkin’s lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphism...

od Blum, K. A., Jung, S.-H., Johnson, J. L., Lin, T. S., Hsi, E. D., Lucas, D. M., Byrd, J. C., Cheson, B. D., Bartlett, N. L.
Izdano 2010

Phase 1 dose-escalation study of IV ixazomib, an investigational proteasome inhibitor, in patients with relapsed/refractory lymphoma

od Assouline, S E, Chang, J, Cheson, B D, Rifkin, R, Hamburg, S, Reyes, R, Hui, A-M, Yu, J, Gupta, N, Di Bacco, A, Shou, Y, Martin, P
Izdano u Blood Cancer J (2014)

A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin’s lymphoma (NHL): CALGB 50803 (Alliance)

od Martin, P, Jung, S -H, Pitcher, B, Bartlett, N L, Blum, K A, Shea, T, Hsi, E D, Ruan, J, Smith, S E, Leonard, J P, Cheson, B D
Izdano u Ann Oncol (2017)

The role of body mass index in survival outcome for lymphoma patients: US intergroup experience

od Hong, F., Habermann, T. M., Gordon, L. I., Hochster, H., Gascoyne, R. D., Morrison, V. A., Fisher, R. I., Bartlett, N. L., Stiff, P. J., Cheson, B. D., Crump, M., Horning, S. J., Kahl, B. S.
Izdano u Ann Oncol (2014)

Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for Advanced Hodgkin Lymphoma in the Modern Era

od Diefenbach, C. S., Li, H., Hong, F., Gordon, L. I., Fisher, R. I., Bartlett, N. L., Crump, M., Gascoyne, R. D., Wagner, H., Stiff, P. J., Cheson, B. D., Stewart, D. A., Kahl, B. S., Friedberg, J. W., Blum, K. A., Habermann, T. M., Tuscano, J. M., Hoppe, R. T., Horning, S. J., Advani, R. H.
Izdano u Br J Haematol (2015)